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In Brief
The enzyme activation-induced cytidine
deaminase (AID) mutates antibody genes
in B lymphocytes, leading to enhanced
immunity; however, off-target AID activity
can lead to cancer. The structure of AID is
not known. King et al. use a combination
of computer simulations and functional
experiments to uncover how AID activity
is regulated.
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Activation-induced cytidine deaminase (AID) mu-
tates cytidine to uridine at immunoglobulin loci
to initiate secondary antibody diversification but
also causes genome-wide damage. We previously
demonstrated that AID has a relatively low catalytic
rate. The structure of AID has not been solved.
Thus, to probe the basis for its catalytic lethargy we
generated a panel of free or DNA-bound AID models
based on eight recently resolved APOBEC struc-
tures. Docking revealed that the majority of AID:DNA
complexes would be inactive due to substrate bind-
ing such that a cytidine is not positioned for deami-
nation. Furthermore, we found that most AID confor-
mations exhibit fully or partially occluded catalytic
pockets. We constructed mutant and chimeric AID
variants predicted to have altered catalytic pocket
accessibility dynamics and observed significant cor-
relation with catalytic rate. Data frommodeling simu-
lations and functional tests of AID variants support
the notion that catalytic pocket accessibility is an
inherent bottleneck for AID activity.
INTRODUCTION
Activation-induced cytidine deaminase (AID) initiates DNA le-
sions at immunoglobulin (Ig) loci that mediate antibody diversifi-
cation (Muramatsu et al., 1999, 2000). Inherited defects in AID
result in hyper IgM immunodeficiency (Muramatsu et al., 2000;
Revy et al., 2000). AID also acts genome-wide, leading to can-
cer-drivingmutations and chromosomal translocations (Pasqua-
lucci et al., 2008; McCarthy et al., 2003; Okazaki et al., 2003;
Ramiro et al., 2004; Klemm et al., 2009). Human AID is 198 amino
acids long and is a member of the apolipoprotein B mRNA
editing enzyme catalytic polypeptide-like (APOBEC) family of
Zn-dependent, single-stranded polynucleotide-restricted cyti-
dine deaminases (Muramatsu et al., 1999; Conticello et al.,
2007a; Conticello, 2008). It converts deoxycytidine (dC) to deox-
yuridine (dU) in single-stranded DNA (ssDNA) preferentially in
WRC (W = A/T, R = A/G) motifs (Sohail et al., 2003; Larijani andStructure 23Martin, 2007; Larijani et al., 2005; Pham et al., 2003). We previ-
ously showed that AID binds ssDNAwith high affinity in the nano-
molar range (Larijani et al., 2007). We demonstrated that AID has
a significantly lower catalytic turnover rate compared with most
enzymes, mediating a reaction every 1–4 min, a finding that has
since been confirmed by others (Pham et al., 2011). We postu-
lated that this lethargy represents an evolutionary built-in safe-
guard (Larijani et al., 2007; Larijani and Martin, 2012). That AID
mutants with increased catalytic rates mediate higher levels of
double-stranded DNA breaks when transfected into cells sup-
ports this notion (Wang et al., 2009). The three-dimensional
structure of AID has eluded resolution due to extensive nonspe-
cific interactions interfering with absolute purification (Larijani
and Martin, 2012; Coker et al., 2006). Hence, molecular determi-
nants underlying its slow catalytic rate and other biochemical
properties remain unknown.
To gain insight into its structure, we and others have presented
several models of AID. In 2007, Prochnow et al. (2007) modeled
AID based on the crystal structure of truncated APOBEC2
(A241–224), which formed a rod-shaped tetramer. Several hyper
IgM-causing mutations were found in the predicted oligomeric
interfaces, suggesting that AID forms a tetramer similar to A2.
This is consistent with our previous observation that active AID
is enriched in fractions corresponding to dimers or tetramers in
size (Larijani et al., 2007). It is noteworthy that A2 itself is inactive
(Conticello, 2008) and that the tetrameric crystal structure was
obtained from a truncated human A241–224 while full-length
mouse A2 was later shown to be a monomer by nuclear mag-
netic resonance (NMR) (Krzysiak et al., 2012). Other studies
showed AID, APOBEC3A(A3A), and APOBEC3G (A3G) can be
active in vitro as monomers (Brar et al., 2008; Byeon et al.,
2013; Opi et al., 2006). In 2008, Patenaude et al. (2009) pre-
sented a dimeric AID model, based on A241–224, to illustrate
that residues mediating cytoplasmic-nuclear shuttling formed a
nuclear localization signal (NLS). In 2009 and 2010, two studies
presented a partial model of a loop region that when trans-
planted between AID and A3G/A3F transfers sequence speci-
ficity of the donor (Kohli et al., 2009; Carpenter et al., 2010).
Consistent with its role in substrate specificity, in 2012, Wije-
singhe et al. showed that the same loop mediates the difference
between AID and A3A in the ability to deaminate 50-methylated
cytidines (5mC) (Wijesinghe and Bhagwat, 2012). In 2012 and
2013, we presented several core and surface charge/topology
models of bony fish and human AID. These models were based, 615–627, April 7, 2015 ª2015 Elsevier Ltd All rights reserved 615
Figure 1. Primary Structure Alignment of AID and APOBEC Modeling Templates
AIDwas alignedwith APOBEC2, 3A, 3C, 3F-CTD, and 3G-CTD, which served as templates formodeling AID (see also Figure S1 for APOBEC template structures).
The secondary structure of A3G-CTD X-ray (PDB: 3e1uA) was used to denote a-helical, b strand, and loop regions, thus providing an approximation of the
secondary structure shared within the family. Every tenth residue is numbered using AID as a reference. *Zn-coordinating and catalytic residues conserved
among the family. Residues are colored according to side chain chemistry. The red to blue conservation bar under each sequence illustrates differentially ho-
mologous portions of each APOBEC, with red and blue representing nonconserved and conserved, respectively.on the resolved partial A3G structure template and had features
that could explain differences in biochemical properties among
bony fish and human AID (Larijani and Martin, 2012; Dancyger
et al., 2012; Abdouni et al., 2013).
The aforementioned AID models had several limitations. First,
each was focused on one region of interest, not taking into ac-
count the impact of neighboring motifs. Second, these models
were constructed from single templates. Here, we used eight
recently solved full or partial APOBEC structures to generate a
large panel of AID models with and without bound DNA. This
approach allowed us to examine the probabilities of different
structural conformations as well as to distinguish portions of
the structure that are likely to be more rigid versus flexible. We
found that the majority of AID:DNA interactions do not lead to
deamination and that breathing restriction of its catalytic pocket
is a major bottleneck to AID activity. To test this functionally, we
generated AID mutants and chimeric variants predicted to have
altered catalytic pocket accessibility dynamics. Enzyme kinetic
analysis of these variants revealed significant correlation be-
tween the degree of catalytic pocket accessibility and catalytic
rate, supporting the model that restriction of its catalytic pocket
is an inherent regulator of AID activity.
RESULTS AND DISCUSSION
Suitability of Resolved APOBEC Structures to Model
Various AID Conformations
There are 11 human APOBEC enzymes: APOBEC1 (A1),
APOBEC2 (A2), APOBEC3A–H (A3A–H), APOBEC4, and AID
(Conticello et al., 2005, 2007a). Among these, eight partial or
complete structures have been described to date. These include
the NMR solution structure of full-length mouse A2, X-ray crystal
structures of either the inner (chain A) or outer (chain B) mono-616 Structure 23, 615–627, April 7, 2015 ª2015 Elsevier Ltd All rightsmers of the human A241–224 tetramer, NMR solution structure
of A3A, X-ray crystal structure of A3C5–190, X-ray crystal struc-
ture of A3F C-terminal domain (CTD), and the X-ray crystal and
NMR solution structures of A3G-CTD (Prochnow et al., 2007;
Krzysiak et al., 2012; Byeon et al., 2013; Kitamura et al., 2012;
Bohn et al., 2013; Holden et al., 2008; Furukawa et al., 2009) (Fig-
ure S1). All APOBECs have a conserved core architecture akin to
that of human cytidine deaminase, consisting of an a-b-a Zn2+
binding motif, which is H-X-E-X(23–28)-P-C-X(2–4)-C (Conticello
et al., 2007a; Conticello, 2008; Smith et al., 2012). This catalytic
pocket is characterized by its core 4- or 5-stranded b sheet un-
derlying two neighboring a helices that converge to bring the
conserved Zn2+ coordinating residues (two cysteines and a his-
tidine) into proximity with the glutamic acid required for deamina-
tion catalysis (Figure S1) (Abdouni et al., 2013; Conticello et al.,
2005; Smith et al., 2012; Munk et al., 2012). Among the APOBEC
enzymes with determined structures, A2, A3A, A3C, A3G-CTD,
and A3F-CTD exhibit 46.9%, 56.6%, 52.5%, 55.6%, 54.3% res-
idue homology, and 33.5%, 42.7%, 44.6%, 46.6%, and 42.9%
residue identity with AID, respectively (Figure 1). All exhibit suffi-
cient homology and spread of identical or homologous residues
to serve as appropriate templates for modeling AID. However,
various sections of the sequence of AID are differentially homol-
ogous to each APOBEC. Therefore, considering a single tem-
plate for modeling AID in its entirety may not provide an accurate
picture. Even for the same APOBEC, there are often conforma-
tional differences between crystal and solution structures (Fig-
ure S1) (Schneider et al., 2009; Igumenova et al., 2006). Indeed,
each structure itself may also include multiple energetically
favorable conformations such as the 30 NMR conformations in
the A3A NMR ensemble (Byeon et al., 2013). Thus, we reasoned
that generating a cohort of AID models from multiple templates
may provide insights on the likelihood of different conformations.reserved
Figure 2. Superimposed AID Models from Different APOBEC Templates Highlight Regions of Conformational Flexibility
(A) AID models based on mouse A2 NMR (PDB: 2rpzA).
(B) AID models based on A3A NMR (PDB: 2m65A).
(C) AID models based on A3C X-ray (PDB: 3vowA).
(D) AID models based on A3F-CTD X-ray (PDB: 4iouA).
(E) AID models based on A3G-CTD X-ray (PDB: 3e1uA).
(F) AID models based on A3G-CTD NMR (PDB: 2kboA).
(G) AID models based on A241–224 chain A (PDB: 2nytA).
(H) AID models based on A241–224 chain B (PDB: 2nytB).
(I) Superimposition using a representative high-probability model derived from each template (see also Tables S1 and S2 and Figure S2 for validation of our
modeling approach involving the APOBEC templates and for description of QMEAN6 and stereochemical qualities of each AIDmodel). Each template yielded five
low-energy conformations of AID (except mouse A2, which yielded four), totaling 39models. For each of the eight templates, we superimposed the models using
a unique color for each model. The purple sphere represents the coordinated zinc in the putative catalytic pocket. The arrow in (A) points to a7, which was
modeled ab initio. a7 hasmore rotational freedom and adopts multiple conformations in our models, likely because it is unrestricted on its C-terminal end. In each
superimposition, the basic secondary structure is conserved, while the connecting loops display increased flexibility.By then examining how these conformational dynamics influ-
ence the putative catalytic pocket of AID, aswell as DNAbinding,
we could gain insights into the structural determinants of its
enzymatic activity.
Quality Assessment andGeneral Features of AIDModels
To validate our approach, we focused on the seven APOBEC
family member structures that have been resolved and can be
used as templates to model AID. We used four (mouse A2, hu-
man A241–224, A3G-CTD X-ray, and NMR structures) as tem-
plates to model the other three (A3A, A3C, and A3F-CTD). We
generated 34 model structures and evaluated the fit of each
model with its cognate resolved structure by superimposition
(Figure S2). For each model:structure pair we used the global
root-mean-square (rms) measure of peptide backbone as well
as side chain conformation alignments, determined as the
average rms of all residues (Table S1). We found that 25/34
models yielded rms values <3 A˚ indicating acceptable fit. Thus,Structure 23we concluded that our approach can produce high-fidelity
models.
For AID models based on each of the eight templates, we
examined 4 or 5 of the most energetically favorable conforma-
tions, totaling 39 models (Figure 2). All AID models contain a
core structure comprising a central b sheet with four or five b
strands (dependent upon the b2 strand conformation) sand-
wiched between six a helices, connected by intervening loops
similar to the core APOBEC structure. However, compared
with other APOBECs, AID contains an additional 18 nonhomolo-
gous residues in the C terminus (Figure 1) which we had tomodel
ab initio. This C-terminal region forms an a helix (a7) that can as-
sume multiple conformations relative to the core. We assessed
overall model quality using both qualitative and quantitative
measures. We compared the features of models (Figures 3A
and 3B) against known biochemical properties of AID (Sohail
et al., 2003; Pham et al., 2003; Larijani et al., 2007; Pham et al.,
2011; Larijani and Martin, 2012). First, all models recapitulate, 615–627, April 7, 2015 ª2015 Elsevier Ltd All rights reserved 617
Figure 3. Highly Conserved Features among
Models Support Biochemical Characteris-
tics of AID
(A) Representative ribbon model of AID. All AID
models recapitulate the conserved APOBEC core
architecture, with the exception of the unique-to-
AID C-terminal loop 12 and a7. N to C terminus
progression is shown from blue to red, with cata-
lytic pocket zinc shown in purple.
(B) General surface topology of AID. Positive,
neutral, and negative residues are blue, white, and
red, respectively, with the putative catalytic pocket
surface colored inmagenta. The surface contains a
high proportion of positively charged residues lin-
ing two potential ssDNA binding grooves that pass
over the putative catalytic pocket, approximately
denoted by yellow dots.
(C) The putative catalytic pocket of AID is charac-
terized by Zn-coordinating (H56, C87, and C90)
and catalytic (E58) residues. The catalytic motif is
positioned at the N termini of a2 and a3 above the
central b sheet.
(D) dC docked into a representative catalytic
pocket. dC docking was carried out in the context
of a 7-mer ssDNA substrate, but only the dC is
shown. Magenta denotes the surface topology of
the putative catalytic residues that form a pocket
large enough to accommodate dC, and nearby
residues that are likely involved in dC stabilization
are shown.the canonical position of the three Zn-coordinating residues
(H56, C87, and C90) above a glutamic acid residue (E58), the
equivalent of which in all other cytidine/cytosine deaminases
serves as the catalytic proton-donating residue for deamination
(Figure 3C) (Conticello et al., 2007b). Second, this catalytic motif
forms an indented pocket on the surface with dimensions and
electrostatic properties that allow docking of a dC nucleotide
in deamination-feasible conformations (Figure 3) (Larijani and
Martin, 2012; Dancyger et al., 2012; Abdouni et al., 2013). That
a viable catalytic pocket is formed by the three-dimensional
convergence of the four catalytic residues from throughout the
model (a2, a3, loops 2, 4, 6, and 8), provides overall confidence
(Figures 3A–3D). Third, the surface contains a high proportion of
positively charged residues, many of which fall in one of two pu-
tative ssDNA binding grooves passing over the putative catalytic
pocket (Figure 3B). These are on average 6 A˚ wide, wide
enough to accommodate ssDNA. These features are consistent
with the ability of AID to bind exclusively ssDNA with high affinity
(Larijani et al., 2007; Dickerson et al., 2003). To quantitatively
assess the models, we conducted QMEAN6 Z score and Rama-
chandran analysis (Table S2). All AID models showed favorable
QMEAN6 Z scores (–1.79, –1.49, –1.39, –2.27, –1.64, –1.74,
–1.72, and –1.19 on average, respectively). In addition, AID
models based on mouse A2, A241–224 chain A and B (X-ray),
A3A (NMR), A3C (X-ray), A3F-CTD (X-ray), A3G-CTD (NMR),
and A3G-CTD (X-ray) templates contained the majority of resi-
dues situated within favored regions of the Ramachandran plots
(87.1%, 87.1%, 88.1%, 82.8%, 84.5%, 82.1%, 81.5%, and
87.1%, respectively), as shown in Table S2. By thus scrutinizing
the models against qualitative and quantitative criteria, we
conclude that they are reliable.618 Structure 23, 615–627, April 7, 2015 ª2015 Elsevier Ltd All rightsPutative Catalytic Pocket Architecture and Implications
for Deamination Catalysis
Converging at the base of the putative catalytic pocket, H56 is
located at the C terminus of loop 4, E58 at the N terminus of
a2, C87 at the N terminus of loop 6, and C90 at the N terminus
of a3 (Figures 3A and 3C). This putative catalytic pocket orga-
nization supports an ordered deamination reaction chemistry
that is typical of other cytidine/cytosine superfamily deami-
nases (Conticello, 2008; Losey et al., 2006). After Zn2+ binds
an activated water molecule, thus forming the Zn-OH nucleo-
phile, AID is primed for deamination (Figure S1H) through
an ordered reaction mechanism, as previously suggested
(Conticello et al., 2007a; Abdouni et al., 2013). Besides these
Zn-coordinating and catalytic residues, we note secondary
catalytic residues that compose the walls and floor of the cat-
alytic pocket. These do not directly participate in deamination,
but are predicted by the models to contact and/or stabilize the
substrate dC in several conformations through hydrogen
bonding, electrostatic interactions, and aromatic base stack-
ing. Therefore, these residues are likely to play crucial roles
in the catalytic activity of AID. By examining all AID:ssDNA
docked complexes in which dC was in the putative catalytic
pocket, we identified 21 potential secondary catalytic residues
(Figure 4A). Among these, T27, N51, and W84 were observed
in 63%–75% of models. R25, V57, S85, P86, and Y114 were
observed in 25%–50% of models. R24, E26, K52, F115, G23,
L29, N53, G54, C55, T82, D89, C116, and E122 were observed
in 6%–18% of the models. These residues are located pre-
dominantly on loops that form the catalytic pocket. G23,
R24, R25, E26, T27, and L29 are in loop 2. N51, K52, G54,
C55, and V57 are in loop 4. T82, W84, S85, and P86 residereserved
Figure 4. Secondary Catalytic Residues Regulate the Chemical Microenvironment of the Catalytic Pocket
(A) Secondary catalytic residues from loop 2 (R25, T27), loop 4 (N51, V57), loop 6 (W84, S85, P86), and loop 8 (Y114) that were found to be proximal to docked dC
in the majority of AID:ssDNA complexes, at three viewing angles (left, middle, and right panels). In all docks, the carbonyl of dC is hydrogen bonded by the amide
group of N51 or the hydroxyl group of Y114. The docked dC carbons are colored green.
(B) AID:ssDNA complexes illustrating four deamination-supporting orientations of dC in the catalytic pocket (from left to right: perpendicular 1, perpendicular 2,
planar 1, and planar 2). Together, perpendicular 2 and planar 2 orientations comprise the majority of dC-bound complexes. In all orientations, dC carbonyl is
stabilized by hydrogen bonds, with one or more conserved residues lining the pocket.
(C) Y114 and W84 stabilize dC through base stacking and hydrophobic contacts. In the majority of conformations with dC bound in the catalytic pocket, W84 is
located lying planar relative to the floor of the catalytic pocket, base stacking dC (left panel). In some conformations, Y114 adopts a side-on conformation, where it
base stacks with W84 (right panel). In either case, the C5 and C6 of dC are in contact with W84 and/or Y114. Together, W84 and Y114 appear to stabilize the
aromatic ring of dC and shield its nonpolar regions from the largely polar microenvironment of the catalytic pocket.in loop 6. Y114, F115, and E122 are in loop 8. D89 is in a3, and
E122 is in a4.
Using the catalytic and secondary catalytic residues as refer-
ence, we examined deamination-feasible conformations of
docked dC in the catalytic pocket (Figure 4B). Each complex
was defined by the directionality of the dC carbonyl group:
planar 1 (carbonyl facing N51), planar 2 (carbonyl facing away
from N51), perpendicular 1 (carbonyl facing away from the floor
of the catalytic pocket), and perpendicular 2 (carbonyl facing to-
wards the floor of the catalytic pocket). Planar 1 and perpendic-
ular 2 conformations represent 50% (8/16) and 25% (4/16) of
clusters, respectively, while planar 2 and perpendicular 2 each
represent 2/16 (12.5%) of docks. Thus planar 1 represents theStructure 23most energetically favorable dC conformation. We found that
in 63% of dC docked complexes (including all planar 1 and
perpendicular 1 conformations) the dC carbonyl group was sta-
bilized by hydrogen bonding with the amide group of N51. We
noted that first, mutation of the N51 equivalent residue (N244A
in A3G, N57A in A3A) abolished deamination (Holden et al.,
2008; Bulliard et al., 2011); second, the equivalent residue in
Staphylococcus aureus tRNA adenosine deaminase TadA
(N42) has been shown to stabilize its substrate in the catalytic
pocket by hydrogen bonding (Losey et al., 2006); and third,
N51 is 100% conserved among all active APOBECs (Figure 1).
In the remaining 37% of conformations (planar 2 and perpen-
dicular 2 conformations), the dC carbonyl was stabilized by a, 615–627, April 7, 2015 ª2015 Elsevier Ltd All rights reserved 619
combination of polar groups in S85, C116, R25, Y114, and T27
(Figures 4A and 4B). In addition to polar interactions with dC
carbonyl, we also noted significant nonpolar interactions and
base stacking of the pyrimidine ring. Two aromatic residues,
W84 (loop 6) and Y114 (loop 8), are located on the floor and walls
of the catalytic pocket, respectively (Figure 4C). In 63%and 50%
of docks, the aromatic ring of dC was base stacked with the ar-
omatic rings of W84 or Y114, respectively. In this manner, W84
and Y114 may stabilize the nonpolar regions of dC and shield
these from the otherwise polar microenvironment of the pocket.
Recently, we and others have discussed the importance of Y114
in the context of the catalytic pocket of AID (Wijesinghe and
Bhagwat, 2012; Abdouni et al., 2013). Of the secondary catalytic
residues, Y114 adopts the most diverse range of conformations
in the context of its angular attitude within the catalytic pocket of
the AID models. Indeed, it is partially a consequence of these
variations that dC is able to dock in several planar and perpen-
dicular conformations, as described above (Figure 4B). Thus,
while the primary catalytic residues are responsible for deamina-
tion, it is likely that the makeup and arrangement of secondary
residues affect deamination efficiency through dC stabilization
and modulating the chemical properties of the catalytic pocket.
Catalytic Pocket Accessibility of AID Is a Key
Determinant of Its Catalytic Rate
Deamination is not possible if dC cannot access the catalytic
pocket. To examine the fit of dC in the catalytic pocket, we simu-
lated a 7-nucleotide-long ssDNA containing either a WRC motif
(TGC) or a control non dC-containing ssDNA (TGT). We found
that only 25.6% (10/39) of models bound dC in the catalytic
pocket in conformations that allowed access to Zn and E58 (Fig-
ure 5A). Bound conformations exhibited catalytic pockets
spacious enough (average dimensions of pocket 5.6 x 4.9 x
6.7 A˚) to allow dC (dimensions 6.4 x 4.3 x 6.6 A˚) access to Zn
and E58 (Figure 5A). 25.6% (10/39) of models formed a partially
open catalytic pocket (average dimensions 4.1 x 3.6 x 7.3 A˚),
while the remaining 49% (19/39) of models exhibited nearly or
fully collapsed catalytic pockets with no apparent surface pocket
(Figures 5A and 5B). As expected, we found dC docked only in
catalytic pockets of models with accessible pockets in confor-
mations that were energetically favorable and would allow for
deamination. As evident by the average dimensions of acces-
sible pockets and dC, even among these, the substrate fit was
taut (Figure 5C). These observations led us to hypothesize that
the catalytic pocket of AID is at best marginally accessible to
dC, thus explaining the low catalytic rate of AID. This hypothesis
is founded on the premise that the relative proportion of time the
catalytic pocket may exist in an accessible versus occluded
conformation is a determinant of the catalytic efficiency of AID.
If this is the case, it would follow that altering accessibility
states of the catalytic pocket of AID ought to influence catalytic
rates accordingly. Thus, we sought to design AID mutants or
chimeric variants that would influence catalytic pocket accessi-
bility. To this end, we examined the portions of AID that are likely
to affect accessibility dynamics of the catalytic pocket (Figures
6A and 6B). Given that the basic arrangement of Zn-coordinating
and catalytic residues is identical among APOBECs, it would
stand to reason that one of the structural differences that medi-
ates variations in catalytic robustness of APOBECsmay lie in the620 Structure 23, 615–627, April 7, 2015 ª2015 Elsevier Ltd All rightsmakeup and positioning of secondary catalytic residues. As
noted in the preceding section, the majority of secondary cata-
lytic residues that make up the floor and walls of the catalytic
pocket are contained in loops 2, 4, 6, and 8. Due to the extreme
conservation of loop 6 (Figure 1) and transplantation of loop 8
(substrate specificity loop) having no effect on the catalytic
rate of AID (Kohli et al., 2009; Carpenter et al., 2010), it is less
likely that these regions alter catalytic pocket restriction. In
contrast, loop 2, loop 4, and a3 all converge around the catalytic
pocket and likely control access to the catalytic pocket. We
noted significant variability in the length and amino acid compo-
sition of these loops among various APOBECs, and as a conse-
quence, a high degree of conformational variability between
resolved APOBEC structures and within our cohort of AID
models (Figure 2I; Figure S1). It thus appeared that differences
in length and composition of these loops among APOBECs
may underlie their degree of movement restriction, which would
in turn affect catalytic pocket accessibility through modulating
positions and/or angles of the secondary catalytic residues
that make up its walls and floor.
With this rationale, we constructed 19 AIDmutants or chimeric
variants bearing alterations in loop 2, loop 4, and a3 (Figures 6A
and 6B). As we had done for wild-type AID, we examined the
accessibility of the catalytic pockets in a cohort of models for
each AID variant (756 models, which generated 24,192 AID-
DNA complexes, in total). We then compared the fraction of
models with accessible catalytic pockets that were able to
dock dC between each variant and wild-type AID (Table S3). In
parallel, we compared the maximal measured catalytic rate of
each variant to wild-type AID (Figure 6C). First, we examinedmu-
tants of residues in loops 2 and 4, which compose the catalytic
pocket walls and floor and should modulate catalytic activity.
We found that mutations in loop 2 (K22D, R25A, R25D, T27V,
and T27D) and loop 4 (N51A, N51Q, and K52D) resulted in
60%–80% fewer conformations able to dock dC in the catalytic
pocket (Table S2). Accordingly, these mutants had lower cata-
lytic rates compared with wild-type AID or were inactive (Fig-
ure 6C). T82I was the only mutant to have slightly more confor-
mations able to dock dC relative to wild-type AID. Accordingly,
it has been shown to be slightly more active than human AID
(Wang et al., 2009).
We then investigated the role of loop 4, in its entirety, in modu-
lating catalytic rate through catalytic pocket accessibility. Rela-
tive to AID, A3A and A3G have a loop 4 that is 8 residues longer
(Figure 6A). Because mutation of loop 4 residues modulates cat-
alytic rate, we wondered whether integration of this region from
other APOBECs into an AID scaffold would alter the breathing
dynamics of the catalytic pocket and its activity accordingly.
To this end, we constructed AID-A3A and AID-A3G, incorpo-
rating loop 4 from A3A and A3G into an AID scaffold (Figure 6A).
Simulations revealed that AID-A3G and AID-A3A had 50% and
70% fewer conformations able to dock dC than wild-type AID,
respectively (Table S3). Indeed, we found that both chimeras
had severely reduced activity (Figure 6C).
Next, we sought to examine AID chimeras with a3 region var-
iations. We previously reported that zebrafish AID (Dr-AID) was
more catalytically robust than human AID (Hs-AID) (Dancyger
et al., 2012; Abdouni et al., 2013). We reasoned that one way
to increase the catalytic rate of human AIDmay be to incorporatereserved
Figure 5. The Catalytic Pocket May Assume Conformations that Affect Accessibility
(A) General surface topology of AID. Positive, neutral, and negative residues are shown as blue, white, and red, respectively. The surface of the putative catalytic
pocket surface is shown partially in magenta. Left panel shows a fully accessible catalytic pocket able to accommodate dC and support deamination; however, in
the majority of conformations, the catalytic pocket is partially (middle) or fully (right) restricted, unable to bind dC in energetically favorable conformations that
allowed for deamination.
(B) Zoomed-in surface topology of open (left), partially open (middle), and closed (right) catalytic pockets. Transparent stick format of secondary catalytic residue
side chains is used to show that the catalytic pocket is collapsed due to the protrusion of one or more residue side chains, restricting dC access to catalytic
residues.
(C) In catalytically viable conformations, dC (spheres indicate approximate van der Waals radii) is located in the catalytic pocket, forming a tight fit. The inner
surface of the catalytic pocket is traced by a mesh outline.multiple regions of Dr-AID into a human AID scaffold. To this end,
we constructed three chimeras, which incorporated a3 and adja-
cent loops fromDr-AID into a humanAID scaffold (Figure 6A). We
found that two chimeras (Hs/Dr-AID-1 and Hs/Dr-AID-2) ex-
hibited significantly higher (17%–37% increase) conformations
able to dock dC when compared with wild-type human AID,
while the third chimera (Hs/Dr-AID-3), which incorporates only
the a3 of Dr-AID into the human AID scaffold, exhibited a more
modest (7%) increase in dC accessible catalytic pockets
(Table S3). Correspondingly, Hs/Dr-AID-1 and Hs/Dr-AID-2Structure 23had dramatically increased catalytic rates when compared with
human AID, while Hs/Dr-AID-3 had a more modest increase in
catalytic rate (Figure 6C). To further examine the role of catalytic
pocket accessibility on activity, we generated chimera Hs/Dr-
A3A-AID, which incorporates loop 4 from A3A into Hs/Dr-AID-2
(Figure 6A). As discussed above, the transplantation of A3A
loop 4 into AID resulted in diminished pocket accessibility and
catalysis. This loop transplant mediated a similar effect here,
as shown by our finding that Hs/Dr/A3A-AID had 90% fewer
conformations bound to dC than human AID (Table S3)., 615–627, April 7, 2015 ª2015 Elsevier Ltd All rights reserved 621
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Correspondingly, we found that Hs/Dr/A3A-AID had approxi-
mately 5% of the activity of human AID (Figure 6C). Beyond
AID variants, a secondary prediction of our hypothesis would
be that differences in catalytic pocket accessibility may also
explain the different catalytic rates among various APOBEC en-
zymes. In support of this notion, we note that the experimentally
determined NMR solution structure of A3A indeed includes con-
formations with open as well as occluded catalytic pockets (Opi
et al., 2006). Moreover, in contrast to AID, a larger proportion of
A3A conformations exhibit a fully open catalytic pocket (67%
versus 25.6%). This observation is notable given that A3A is a
catalytically robust enzyme (Mitra et al., 2013; Love et al., 2012).
As summarized in Figure 6D, when ranked according to cata-
lytic pocket accessibility versus catalytic rate, we observed a
significant positive correlation between these two parameters.
Interestingly, this relationship does not appear to be linear, as
relatively modest changes in pocket accessibility can result in
an order of magnitude change in catalytic rate (e.g., Hs/Dr-
AID-1 and Hs/Dr-AID-2). Conversely, in some cases (e.g.,
Dr-AID) relatively modest changes in catalytic rate are not asso-
ciated with significant changes in catalytic pocket accessibility.
In this context, it is crucial to note that our hypothesis that cata-
lytic site accessibility is an important determinant of catalytic rate
does not preclude other factors from influencing catalytic rate.
For instance, N51Q introduces a bulkier side chain that pro-
trudes into the catalytic pocket, thereby reducing the size of
the catalytic pocket and abolishing activity. On the other hand,
a different mutation of the same residue (N51A) does not affect
the physical size of the pocket, yet it also reduces the ability to
dock dC and abolishes activity (Table S3; Figure 6D). As dis-
cussed above, N51 is absolutely conserved in closely and
distantly related active deaminases, and as predicted by our
models, it likely plays a crucial role in dC stabilization through
hydrogen bonding of the dC carbonyl group with its amide side
chain. Thus, unlike N51Q, the effect of N51A on catalysis cannot
be explained by the physical occlusion of the catalytic pocket,
but rather by the lack of the amide group, thus perturbing the
chemistry of the catalytic pocket required to stabilize dC. These
results support the model that catalytic pocket accessibility is a
rate-limiting step in deamination catalysis by AID. The data also
further corroborate the validity of our modeling and docking ap-
proaches by demonstrating their ability to predict dynamic
changes in catalytic pocket states that are in line with enzyme
activity data.Figure 6. Modulation of Catalytic Pocket Accessibility Dynamics and C
(A) Sequence alignment of Hs-AID, Dr-AID, APOBEC3A, APOBEC3G-CTD, and
chimeras were derived from the human AID scaffold, with regions from Dr-AID
sequence.
(B) General structural regions of wild-type human AID, illustrating regions trans
respectively.
(C) Enzyme kinetic analysis of initial deamination velocities of AID variants. Subst
from several minutes to 3 hr. High-activity variants are shown using solid black
variants are shown with colored lines. Enzymatically inactive mutants (R25D, T2
discriminate from low-activity mutants. Lines are not shown for these inactive m
(D) Correlation between catalytic rate and catalytic pocket accessibility of wild-
catalytic pocket accessibility predictions). Frequencies of catalytic pocket acce
ranked within the cohort of AID variants and ordered from lowest on the left to high
by enzyme kinetics were ranked within the cohort and ordered from lowest on
p < 0.0001). Error bars indicate SEM.
Structure 23The Role of DNA Binding in Deamination Catalysis
Before deamination catalysis, ssDNA ought to be bound on the
surface of AID in a manner that positions dC in the catalytic
pocket. As mentioned above, we observed two putative ssDNA
binding grooves passing over the catalytic pocket (Figures 3B
and 7A). In AID:ssDNA docking simulations, we identified 50
surface residues with probable contact with ssDNA when dC
is bound in the catalytic pocket (Table S4). The majority of con-
tacts consisted of negatively charged phosphodiester back-
bone interactions with positively charged arginines or lysines.
We observed ssDNA bound on multiple surface locations in
sporadic configurations. This is not surprising given the posi-
tively charged surface. Even when we restricted the docking
search space to the surface area proximal to the catalytic
pocket, we observed that approximately only half of the simu-
lations (58% or 728/1248 binding clusters) resulted in binding
ssDNA in the putative grooves (Figure 7B). Of these, 38%
(276/728), 31% (223/728), and 31% (229/728) were ssDNA
bound entirely in groove 1 similar to A3A:ssDNA molecular
docks (Bulliard et al., 2011), groove 2, or a combination of re-
gions from both grooves, respectively. To assess the propor-
tion of complexes containing dC bound in the catalytic pocket,
we restricted our analysis to the 320 ssDNA docking clusters
involving the 10 (of 39) models with an accessible catalytic
pocket. In this cohort, we observed that 82.8% (260/320) of
complexes have a vacant catalytic pocket and only 18.8%
(60/320) contained a nucleobase in the catalytic pocket (Fig-
ure 7C). Among these, approximately a third (5%) of catalytic
pockets contained dC in deamination-conducive conforma-
tions, while the rest contained other bases. Considering all
states of the catalytic pocket regardless of dC accessibility,
our modeling and docking results lead us to estimate that
1.3% of all AID-DNA interactions have the potential to result
in cytidine deamination. These calculations derived solely
from our in silico observations are in good agreement with a
recent study that calculated deamination-conducive ssDNA
binding events by AID in solution, derived from enzyme kinetic
assays (Mak et al., 2013). This study suggested that 0.7%–
8.0% of AID-DNA interactions result in dC deamination. Our
data suggest that the actual scenario may lie closer to the
lower end of this range.
In conclusion, we found several mechanisms that govern the
mutagenic activity of AID. Regardless of catalytic pocket
accessibility, all models were capable of binding ssDNA in oronsequences for Catalysis
AID chimeras predicted to alter accessibility to the catalytic pocket. All AID
, A3A, or A3G-CTD transplanted, as indicated by rectangles in each primary
planted and mutated by color. N- and C-terminal are colored red and blue,
rate concentrations ranged from 0.15 to 7.5 nM, with incubation times ranging
lines, wild-type Hs- and Dr-AID are shown with dashed lines, and low-activity
7V, T27D, N51A, N51Q, H56D, and C90F) were incubated for 6 hr or more to
utants.
type AID and AID variants (see also Table S3 for full quantitative analysis of
ssibilities, as defined by the ability to dock dC in the catalytic pockets, were
est on the right, on the x axis. Maximum deamination velocities as ascertained
the bottom to highest on top on the y axis (Spearman correlation, R2 = 0.82,
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Figure 7. Docking of ssDNA on the Surface of AID Illustrating Sporadic DNA Binding and Base Competition for the Catalytic Pocket
(A) Considering only conformations with accessible catalytic pockets, we docked a 7-mer ssDNA containing the WRC motif TGC on the surface of AID and
selected for conformations in which dCwas bound to the catalytic pocket (purple). AID:ssDNA complexes illustrating ssDNA topology (blue) relative to the surface
of AID bound to groove 1 (left), groove 2 (middle), or a more curved conformation involving portions of grooves 1 and 2 (right). In each case, the majority of
interactions consisted of electrostatic binding between the negatively charged phosphodiester backbone of ssDNA and the positively charged residues on the
surface of AID.
(B) Groove 1 binding residues are shown in red (left), groove 2 binding residues in blue (middle), and a third conformation, involving binding residues from both
groove 1 and 2, is shown in green (right). Residues that frequently contact ssDNA through phosphodiester backbone or base interactions are labeled (see also
Table S4 for a description of all ssDNA-contacting residues, contact probabilities, and chemical nature of contacts).
(C) Besides dC in the catalytic pocket (left panel), we noted full or partial entry of other bases. We noted an equal number of T2 (from TGC) bound (middle) and a
small proportion of AID:ssDNA complexes that showed a portion of G1 in the catalytic pocket (right). The ssDNA backbone is shown in green.outside the putative ssDNA binding grooves. Even considering
the minor fraction of AID:ssDNA complexes in which ssDNA
passes directly over accessible catalytic pockets, dC was
not positioned in the catalytic pocket in the majority of ssDNA
binding events. In the context of our suggestion here that cata-
lytically inactive conformations likely represent the predomi-
nant breathing form of AID, it stands to reason that binding
of ssDNA to inactive conformations of AID or on surface loca-
tions that do not pass over the catalytic pocket and/or do not
position a dC into the pocket limit deamination catalysis. Our
data suggest that conformational breathing restriction of its
catalytic pocket as well as frequent catalytically nonviable
ssDNA binding are mechanisms inherent to AID that collec-
tively limit its activity.624 Structure 23, 615–627, April 7, 2015 ª2015 Elsevier Ltd All rightsEXPERIMENTAL PROCEDURES
APOBECTemplate Selection, AIDModeling, andEvaluation ofModel
Quality
Eight APOBEC structures were chosen as templates: mouse A2 NMR (PDB:
2RPZ), A241–224 chain A X-ray (PDB: 2NYT, chain A), A241–224 chain B X-ray
(PDB: 2NYT, chain B), A3A NMR (PDB: 2M65), A3C X-ray (PDB: 3VOW),
A3F-CTD X-ray (PDB: 4IOU), A3G-CTD NMR (PDB: 3E1U), and A3G-CTD
NMR (PDB: 2KBO) (Figure S1) (Krzysiak et al., 2012; Byeon et al., 2013; Kita-
mura et al., 2012; Bohn et al., 2013; Holden et al., 2008; Furukawa et al., 2009;
Prochnow et al., 2009). All APOBEC template structures were obtained from
the PDB (http://www.rcsb.org) and visualized using PyMOL v1.3 (http://
www.pymol.org/). Using the default parameters of I-TASSER (http://
zhanglab.ccmb.med.umich.edu/I-TASSER/) (Zhang, 2008; Roy et al., 2012)
full-length human AID (Hs-AID) and variants were modeled from the APOBEC
templates to generate 39–40 models for each. In total, considering wild-typereserved
humanAID and AIDmutants or variants, 795models were constructed. In each
model of AID, the entire protein was homology modeled, with the exception of
the nonhomologous 18 C-terminal amino acids, which were modeled ab initio.
Models were compared using the superimpose function of PyMOL, aligning
structures according to the peptide backbone. Each AID model is referred to
using the template that it is based on in square brackets. To evaluate overall
model quality, QMEAN-6 Z scores were calculated to compare overall model
qualities. Ramachandran plots were generated for each model to check the
stereochemical quality on a residue-by-residue basis using PROCHECK (Ben-
kert et al., 2011; Laskowski et al., 1996).
Definition of Catalytic Pocket and Docking of DNA Substrates
The putative catalytic pocket of AID was defined by Zn-coordinating and cat-
alytic residues (H56, C87, C90 E58 in Hs-AID) as aligned with other APOBECs
(Conticello et al., 2007a; Larijani and Martin, 2012). We defined the catalytic
pocket as the indented space containing the catalytic pocket residues. Di-
mensions of the catalytic pocket were measured using PyMOL. DNA sub-
strates were docked to each AID model using Swiss-Dock (http://www.
swissdock.ch) (Grosdidier et al., 2011a; Grosdidier et al., 2011b). Each sub-
strate was constructed in Marvin Sketch v.5.11.5 (http://www.chemaxon.
com/products/marvin/marvinsketch/), while surface topology and docking
parameters were generated using Swiss-Param (http://swissparam.ch)
(Zoete et al., 2011). These output files served as the ligand file in Swiss-
Dock. Control noncytosine containing (50-TTTGTTT-30) and experimental
(50-TTTGCTT-30 ) ssDNA substrates were chosen, since previous work has
shown these to be preferred substrates of AID (Sohail et al., 2003; Larijani
and Martin, 2007; Pham et al., 2003; Larijani et al., 2007; Xie et al., 2004). AID:
substrate docking simulations for each AID enzyme resulted in 5,000–15,000
binding modes. Eight or more recurring binding modes were clustered based
on rms values. The 32 lowest-energy clusters were selected, thus represent-
ing 256 of the lowest-energy individual binding events for each AID. In total,
25,440 low-energy docking clusters were analyzed for wild-type human
AID, mutants, or variants in UCSF Chimera v1.7 (https://www.cgl.ucsf.edu/
chimera) (Pettersen et al., 2004). Deamination-conducive AID:DNA com-
plexes were defined by the accessibility of dC NH2 substrate group to the cat-
alytic Zn-coordinating and the glutamic acid residues (H56, C87, C90, and
E58 in wild-type human AID). Complexes in which dC was bound in the cat-
alytic pocket but improperly orientated, so as not to allow for deamination
to proceed, were disregarded.
Expression, Purification, and Enzymatic Activity of AID Mutants
Wild-type human GST-AID was expressed and purified as previously
described (Larijani et al., 2007; Dancyger et al., 2012). Using models and
DNA binding simulations as a guide, we constructed mutants by site-directed
mutagenesis, as previously described (Dancyger et al., 2012; Abdouni et al.,
2013). To generate chimeric AID variants, EcoRI fragments encoding the AID
open reading frame were synthesized (Genscript) and cloned into pGEX-5X-3
(GE Healthcare) to generate expression constructs. SDS-PAGE was used to
equalize the amount of purified GST-AID used in experiments. We compared
the catalytic activity of each AID variant in comparison with wild-type using
the alkaline cleavage deamination assay for enzyme kinetics, as previously
described (Larijani et al., 2007; Dancyger et al., 2012; Abdouni et al., 2013).
In all experiments, 7-nucleotide-long bubble substrates containing the
WRC motif TGC were used, as previously described (Larijani and Martin,
2007; Larijani et al., 2007). For substrate generation, 2.5 pmol of the WRC-
containing target strand was 50-labeled with [g-32P] deoxyadenosine triphos-
phate using polynucleotide kinase (NEB), followed by purification through
mini-Quick spin DNA columns (Roche) and annealing of 2-fold excess
(5 pmol) of the complementary strand. Purified substrate ranging in concen-
tration from 0.15 to 7.5 nM was incubated with 0.40 mg AID in 100 mM phos-
phate buffer (pH 7.3) in a volume of 10 ml for all reactions. All AID and variants
were incubated at their optimal temperature of 37C, with the exception of
Dr-AID, which is optimally active at 25C (Dancyger et al., 2012). Enzyme
assay incubation periods ranged from several minutes to 3 hr. Inactive mu-
tants were incubated 6–30 hr to in order to distinguish from mutants or var-
iants with minimal activity levels. The correlation plot was constructed using
catalytic rate and catalytic pocket accessibilities ranked within our cohort of
AID variants.Structure 23SUPPLEMENTAL INFORMATION
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